Risk factor
Poor trading liquidity
Profitability factor
Favourable analyst view
About
PT Medikaloka Hermina Tbk oversees a comprehensive network of general hospitals spanning Indonesia. By December 31, 2021, the company's operations encompassed 43 medical facilities, collectively providing 5,877 beds. In addition to its healthcare services, the firm also participates in investment and educational service ventures. Established in 1985, its headquarters are situated in Jakarta, Indonesia.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITD.
Target Price
The average target price of HEAL.JK is 1570 and suggests 79.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i